Regulatory and technological landscapes are evolving at breakneck speed, creating both obstacles and opportunities for clinical research sites and providers. From updates to ICH E6(R3) proposed coverage in ICH E6 (R3) Annex 2 and an ever-broadening array of technology solutions from technology companies, clinical research organizations (CROs) and sponsors—staying ahead of these changes is not just about compliance—it is about survival and success.
In this webinar, the expert speakers will focus on the complexity and deliver actionable insights for site leaders, sponsors and CROs alike. They will unpack what actually matters, including:
Which regulatory changes are legitimate considerations, which are on the horizon and which are business as usual?
Is new technology making trials more efficient or just adding complexity (and cost)? And most importantly—where is the real opportunity?
The expert speakers will cut through the hype and get real about what is working, what is a total headache and what we all need to do to stay competitive in an industry that is always evolving.
ndustry.
Keywords: Good Clinical Practice, CRO, ICH E6, Regulatory, Regulatory Approval, Regulatory Affairs, Regulatory Compliance, GCP, ICH-E6(R2), Pharmaceutical Regulation, Sites, Quality
Go to Event Website Advertisements